Integrin beta-1 (ITGB1 or CD29) Antibody - FFPE Validated

About the Target

For consistent comparison across experiments, use this antibody to assess Integrin beta-1 with a repeatable workflow. Integrin beta-1 is an adhesion-related target that can shift with substrate composition and mechanical cues. For comparison-heavy studies, consistent sample handling and normalization help reduce run-to-run drift.

In some datasets and protocols, it is referenced by the gene symbol CD29.

Research Context

Perturbations that disrupt integrin engagement or actomyosin tension can reshape localization and complex assembly. Define inclusion criteria and controls early so replicate sets remain interpretable as the dataset grows.

Consider these angles when interpreting target-level changes:

• co-variation with cytoskeletal and scaffold partners
• focal adhesion versus diffuse membrane distribution
• remodeling after changes in substrate or mechanical stress
• effects of adhesion inhibitors or matrix composition

Variant Considerations

For paraffin-embedded samples, fixation history and retrieval strategy matter; this option is aligned to those constraints. This matters because epitope exposure and background can vary with preparation and extraction steps. Standardize key parameters so differences reflect biology rather than handling.

For challenging targets, pairing Integrin beta-1 measurements with a second marker can clarify whether differences arise from regulation, redistribution, or shifts in cell composition within the sample.

When interpreting Integrin beta-1, consider whether changes track with compartment identity, cell density, or perturbation timing; these factors can influence apparent signal without implying a direct causal link.

For multi-run studies, the fixed-section option helps keep Integrin beta-1 trends comparable from experiment to experiment.